Search Within

Andrea V Lopez

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Adult Leukemia (8)
  2. Center for Hematologic Malignancies (8)
  3. Department of Medicine (8)
  4. GSK Faculty (8)
  5. Hematologic Malignancies Research (8)
  6. Hematologic Malignancies, Division of (8)

More Groups

People
  1. Renier Brentjens (8)
  2. Terence Purdon (6)
  3. Anthony Daniyan (4)
  4. Xinghuo Li (3)
  5. Carlos Fernandez De Larrea Rodriguez (2)
  6. Eric Smith (2)

More People

Years
  1. 2021 (1)
  2. 2020 (4)
  3. 2019 (3)
Publications
  1. Cancer Immunology Research (2)
  2. Blood (1)
  3. Blood Cancer Discovery (1)
  4. Cancer Cell (1)
  5. Leukemia (1)
  6. Molecular Therapy (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. Nature Publishing Group (3)
  3. American Society of Hematology (1)
  4. Cell Press (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response
    Journal Article

    Li, X.; Daniyan, A. F.; Lopez, A. V.; Purdon, T. J.; Brentjens, R. J.
    Leukemia (2021)

    Fulltext@MSK | Save
  • Defining an optimal dual-targeted CAR T-cell therapy approach simultaneously targeting BCMA and GPRC5D to prevent BCMA escape– Driven relapse in multiple myeloma
    Journal Article

    de Larrea, C. F.; Staehr, M.; Lopez, A. V.; Ng, K. Y.; Chen, Y.; Godfrey, W. D.; Purdon, T. J.; Ponomarev, V.; Wendel, H. G.; Brentjens, R. J.; more...
    Blood Cancer Discovery (2020)

    Fulltext@MSK | Save
  • CD103(+) cDC1 and endogenous CD8(+) T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
    Journal Article

    Kuhn, N. F.; Lopez, A. V.; Li, X.; Cai, W.; Daniyan, A. F.; Brentjens, R. J.
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Excessive costimulation leads to dysfunction of adoptively transferred T cells
    Journal Article

    Wijewarnasuriya, D.; Bebernitz, C.; Lopez, A. V.; Rafiq, S.; Brentjens, R. J.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Optimization of T-cell receptor-modified T cells for cancer therapy
    Journal Article

    Drakes, D. J.; Rafiq, S.; Purdon, T. J.; Lopez, A. V.; Chandran, S. S.; Klebanoff, C. A.; Brentjens, R. J.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Optimal dual-targeted CAR construct simultaneously targeting BCMA and GPRC5D prevents BCMA-escape driven relapse in multiple myeloma
    Meeting Abstract

    Fernandez de Larrea, C.; Staehr, M.; Lopez, A.; Chen, Y.; Purdon, T. J.; Ng, K. Y.; Wendel, H.; Brentjens, R. J.; Smith, E. L.
    Blood (2019)

    Fulltext@MSK | Save
  • Augmenting CAR T cell mediated anti-tumor efficacy through genetic modification to secrete a novel cytokine IL-36γ
    Meeting Abstract

    Li, X.; Daniyan, A.; Lopez, A.; Purdon, T.; Brentjens, R.
    Molecular Therapy (2019)

    Fulltext@MSK | Save
  • CD40 ligand-modified chimeric antigen receptor T cells enhance antitumor function by eliciting an endogenous antitumor response
    Journal Article

    Kuhn, N. F.; Purdon, T. J.; van Leeuwen, D. G.; Lopez, A. V.; Curran, K. J.; Daniyan, A. F.; Brentjens, R. J.
    Cancer Cell (2019)

    Fulltext@MSK | Save